WO2002077162A3 - Gene (t23490) associe a l'hyperplasie benigne de la prostate - Google Patents

Gene (t23490) associe a l'hyperplasie benigne de la prostate Download PDF

Info

Publication number
WO2002077162A3
WO2002077162A3 PCT/US2002/007728 US0207728W WO02077162A3 WO 2002077162 A3 WO2002077162 A3 WO 2002077162A3 US 0207728 W US0207728 W US 0207728W WO 02077162 A3 WO02077162 A3 WO 02077162A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
benign prostatic
prostatic hyperplasia
bph
corresponds
Prior art date
Application number
PCT/US2002/007728
Other languages
English (en)
Other versions
WO2002077162A2 (fr
Inventor
Prakash Kulkarni
Robert H Getzenberg
William E Munger
Original Assignee
Gene Logic Inc
Japan Tobacco Inc
Prakash Kulkarni
Robert H Getzenberg
William E Munger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Logic Inc, Japan Tobacco Inc, Prakash Kulkarni, Robert H Getzenberg, William E Munger filed Critical Gene Logic Inc
Priority to AU2002250315A priority Critical patent/AU2002250315A1/en
Publication of WO2002077162A2 publication Critical patent/WO2002077162A2/fr
Publication of WO2002077162A3 publication Critical patent/WO2002077162A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention se rapporte de manière générale aux modifications intervenant dans l'expression génétique de l'hyperplasie bénigne de la prostate (HBP). L'invention concerne de manière spécifique un nouveau gène humain correspondant à une espèce d'ARN messager qui est exprimé différemment dans un tissu atteint par l'HBP que dans un tissu prostatique normal.
PCT/US2002/007728 2001-03-22 2002-03-14 Gene (t23490) associe a l'hyperplasie benigne de la prostate WO2002077162A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002250315A AU2002250315A1 (en) 2001-03-22 2002-03-14 Gene (t23490) associated with benign prostatic hyperplasia

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27763401P 2001-03-22 2001-03-22
US60/277,634 2001-03-22

Publications (2)

Publication Number Publication Date
WO2002077162A2 WO2002077162A2 (fr) 2002-10-03
WO2002077162A3 true WO2002077162A3 (fr) 2003-04-03

Family

ID=23061729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/007728 WO2002077162A2 (fr) 2001-03-22 2002-03-14 Gene (t23490) associe a l'hyperplasie benigne de la prostate

Country Status (2)

Country Link
AU (1) AU2002250315A1 (fr)
WO (1) WO2002077162A2 (fr)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, NATIONAL LIBRARY OF MEDICINE, BETHESDA MARYLAND; 26 October 2000 (2000-10-26), XP002958750, accession no. STN Database accession no. (BE313844) *

Also Published As

Publication number Publication date
WO2002077162A2 (fr) 2002-10-03
AU2002250315A1 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
WO2001097829A3 (fr) Traitement de substitution enzymatique, therapie genique et therapie par petites molecules pour maladies liees au stockage lysosomal
AU2003224960A1 (en) Steam reforming fuel processor, burner assembly, and methods of operating the same
WO2006015263A3 (fr) Analogues de lonidamine
WO2004050026A3 (fr) Compositions et methodes pour le traitement du cancer de la prostate
IL169685A0 (en) Treatment of benign prostatic hyperplasia using energolytic agents
ZA996622B (en) Treatment of BPH with cGMP elevators.
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AUPQ923100A0 (en) Treatment of prostate cancer
WO2002044360A3 (fr) Arginine deiminase modifiee
WO2006015191A3 (fr) Analogues de lonidamine multicycliques
AU2002360345A1 (en) Prostate cancer genes
WO2003090753A8 (fr) Combinaison pharmaceutique pour le traitement de l'hyperplasie prostatique benigne ou pour la prevention a long terme de la retention urinaire aigue
WO2001098456A3 (fr) Identification d'adnc associes a l'hyperplasie prostatique benigne
WO2002077162A3 (fr) Gene (t23490) associe a l'hyperplasie benigne de la prostate
WO2003008561A3 (fr) Genes associes a l'hyperplasie benigne de la prostate
AU2002220697A1 (en) Isolated luciferases lu164, lual and lu22, and the use of the same
WO2002036826A3 (fr) Gene del-1 et hyperplasie benigne de la prostate
WO2002046362A3 (fr) Gene associe a l'hyperplasie benigne de la prostate chez l'homme
WO2002010338A3 (fr) Expression d'une proteine du type gage/page dans l'hypertrophie benigne de la prostate
WO2002048173A3 (fr) Expression d'une proteine de type cadherine dans une hyperplasie benigne de la prostate
AU2001275264A1 (en) Treatment of fibrous substrates with silsesquioxanes and stainblockers
GB0301016D0 (en) Treatment of benign prostatic hyperplasia
AU2002216009A1 (en) Clinical and functional validation of targets from disseminated cancer cells
AU2003216084A1 (en) Methods for therapeutic treatment of benign prostatic hypertrophy (bph)
AU2001283152A1 (en) Identification of cdnas associated with benign prostatic hyperplasia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP